Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures.
Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches.
This medicine is available only with your doctor’s prescription.
This report contains market size and forecasts of Divalproex Sodium in global, including the following market information:
Global Divalproex Sodium Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Divalproex Sodium Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Divalproex Sodium companies in 2021 (%)
The global Divalproex Sodium market was valued at 2251.9 million in 2021 and is projected to reach US$ 3371.1 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Divalproex Sodium include AbbVie, Mylan, Zydus Pharms USA, Aurobindo Pharma, Dr Reddys Labs, LUPIN, Orchid, Sun Pharm and Teva. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Divalproex Sodium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Divalproex Sodium Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Divalproex Sodium Market Segment Percentages, by Type, 2021 (%)
Tablet
Capsule
Others
Global Divalproex Sodium Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Divalproex Sodium Market Segment Percentages, by Application, 2021 (%)
Epilepsy
Manic-depressive Illness
Others
Global Divalproex Sodium Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Divalproex Sodium Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Divalproex Sodium revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Divalproex Sodium revenues share in global market, 2021 (%)
Key companies Divalproex Sodium sales in global market, 2017-2022 (Estimated), (MT)
Key companies Divalproex Sodium sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Mylan
Zydus Pharms USA
Aurobindo Pharma
Dr Reddys Labs
LUPIN
Orchid
Sun Pharm
Teva

LEAVE A REPLY

Please enter your comment!
Please enter your name here